Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer

Christopher A Chuckran, Anthony R. Cillo, Jessica Moskovitz, Abigail E. Overacre-Delgoffe, Ashwin Somasundaram, Feng Shan, Grant Magnon, Sheryl Kunning, Irina Abécassis, Amer H. Zureikat,

Science Translational Medicine · 2021 · 37 citations · 54 references

DOIFull text

Open access

Concepts

Abstract

Persistent T cell receptor stimulation drives neuropilin-1 on intratumoral regulatory T cells, which is associated with poor clinical outcome.

References

54